Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
13 pending office actions • 10 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
The University of Southampton manages 13 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 13 pending office actions are assigned to 13 distinct examiners. This distribution indicates that each active application is being reviewed by a different individual. The workload is distributed across 10 distinct art units, reflecting a broad technical focus within the biotechnology sector. HERRING, LISA L is the busiest examiner, currently holding 1 busiest examiner pending office action. This single action is part of the larger group of 13 pending office actions.
Navigating 10 distinct art units with 13 distinct examiners requires a highly adaptable prosecution strategy. The university must coordinate across many different technical subgroups, each with its own examination norms, while addressing the specific feedback of 13 different examiners. With 13 pending office actions spread across 10 distinct art units, the university faces a diverse array of patentability challenges. The involvement of 13 distinct examiners ensures that the portfolio is subject to a wide variety of perspectives, which may help in identifying different paths to allowance. However, the lack of concentration under HERRING, LISA L means that the university cannot rely on a single relationship to drive its overall success.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 6 (46%) |
| Double-patenting only | 1 (8%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HERRING, LISA L | 1 | 72.9% | +17.2% |
| XING, CHRISTINA ILONA | 1 | 83.0% | +10.9% |
| FABIAN JR, ROBERTO | 1 | 71.0% | +28.5% |
| VAN DRUFF, SYDNEY | 1 | 55.3% | +32.0% |
| GURLEY, JAMI MICHELLE | 1 | 54.8% | +14.3% |
| CHHAY, BONIRATH | 1 | 62.5% | +0.0% |
| ANTISKAY, BRIAN MICHAEL | 1 | 67.2% | +39.3% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
| CHU, CHRIS H | 1 | 53.1% | +8.6% |
| DENT, ALANA HARRIS | 1 | 44.1% | +32.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837230 | OPTICAL TIME DOMAIN REFLECTOMETRY FOR HOLLOW CORE OPTICAL FIBRES | XING, CHRISTINA ILONA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | DICKINSON, PAUL W | 27d |
| 18993657 | HOLLOW CORE OPTICAL FIBRE DRAWING METHOD WITH MODIFIED DRAWDOWN | HERRING, LISA L | — |
| 18564913 | Suppressive T Cell Populations and Methods of Cancer Immunotherapy | GURLEY, JAMI MICHELLE | — |
| 17297102 | METHOD FOR FABRICATING NANOSTRUCTURED OPTICAL ELEMENTS USING POLARISED LIGHT | EVANGELISTA, THEODORE JUSTINE | — |
| 17270403 | METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE | SHUPE, ELIZABETH A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18651929 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | VAN DRUFF, SYDNEY | 26d overdue |
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | DENT, ALANA HARRIS | 84d |
| 18993657 | HOLLOW CORE OPTICAL FIBRE DRAWING METHOD WITH MODIFIED DRAWDOWN | HERRING, LISA L | — |
| 18837230 | OPTICAL TIME DOMAIN REFLECTOMETRY FOR HOLLOW CORE OPTICAL FIBRES | XING, CHRISTINA ILONA | — |
| 18717742 | MULTI-EXCITATION RAMAN SPECTROSCOPY METHOD AND APPARATUS | FABIAN JR, ROBERTO | — |
| 18564913 | Suppressive T Cell Populations and Methods of Cancer Immunotherapy | GURLEY, JAMI MICHELLE | — |
| 18265580 | REFERENCE ELECTRODE & ION SELECTIVE MEMBRANE | ANTISKAY, BRIAN MICHAEL | — |
| 18037402 | COMPOSITIONS | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1643 | 3 |
| 2877 | 2 |
| 1741 | 1 |
| 1647 | 1 |
| 1645 | 1 |
| 3794 | 1 |
| 1658 | 1 |
| 2874 | 1 |
| 1618 | 1 |
| 3700 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18993657 | HOLLOW CORE OPTICAL FIBRE DRAWING METHOD WITH MODIFIED DRAWDOWN | HERRING, LISA L | 1741 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18837230 | OPTICAL TIME DOMAIN REFLECTOMETRY FOR HOLLOW CORE OPTICAL FIBRES | XING, CHRISTINA ILONA | 2877 | §103 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18717742 | MULTI-EXCITATION RAMAN SPECTROSCOPY METHOD AND APPARATUS | FABIAN JR, ROBERTO | 2877 | §103 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18651929 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | VAN DRUFF, SYDNEY | 1643 | §103 | Non-Final OA | 26d overdue | Pending | May 01, 2024 |
| 18564913 | Suppressive T Cell Populations and Methods of Cancer Immunotherapy | GURLEY, JAMI MICHELLE | 1647 | §101§103§112 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18281530 | NOVEL COMBINATIONS OF ANTIBODIES AND USES THEREOF | CHHAY, BONIRATH | 1645 | §103Other | Final Rejection | — | Pending | Sep 11, 2023 |
| 18265580 | REFERENCE ELECTRODE & ION SELECTIVE MEMBRANE | ANTISKAY, BRIAN MICHAEL | 3794 | §103 | Final Rejection | — | Pending | Jun 06, 2023 |
| 18037402 | COMPOSITIONS | KATAKAM, SUDHAKAR | 1658 | §103DP | Final Rejection | — | Pending | May 17, 2023 |
| 18245273 | HOLLOW CORE OPTICAL WAVEGUIDES AND METHODS FOR MODIFICATION THEREOF | CHU, CHRIS H | 2874 | §103 | Final Rejection | 33d | Pending | Mar 14, 2023 |
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | DENT, ALANA HARRIS | 1643 | DP | Non-Final OA | 84d | Pending | Jan 06, 2022 |
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | DICKINSON, PAUL W | 1618 | §103§112 | Non-Final OA | 27d | Pending | Sep 16, 2021 |
| 17297102 | METHOD FOR FABRICATING NANOSTRUCTURED OPTICAL ELEMENTS USING POLARISED LIGHT | EVANGELISTA, THEODORE JUSTINE | 3700 | §103§112 | Final Rejection | — | Pending | May 26, 2021 |
| 17270403 | METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE | SHUPE, ELIZABETH A | 1643 | §103§112 | Non-Final OA | — | Pending | Feb 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Southampton has 13 pending office actions as of October 2026, spread across 10 art units and 13 examiners.
Lisa L Herring has the most, with 1 of University of Southampton's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
